Get the Stockscreener App
0.3841
7.80%
-0.0325
Clearside Biomedical Inc stock is traded at $0.3841, with a volume of 814.33K.
It is down -7.80% in the last 24 hours and down -51.55% over the past month.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
See More
Previous Close:
$0.4166
Open:
$0.405
24h Volume:
814.33K
Relative Volume:
0.90
Market Cap:
$29.85M
Revenue:
$8.23M
Net Income/Loss:
$-32.49M
P/E Ratio:
-0.7247
EPS:
-0.53
Net Cash Flow:
$-19.91M
1W Performance:
-22.75%
1M Performance:
-51.55%
6M Performance:
-58.70%
1Y Performance:
-66.01%
1-Day Range:
$0.38
$0.42
1-Week Range:
$0.38
$0.57
52-Week Range:
$0.292
$1.65
Clearside Biomedical Inc Stock (CLSD) Company Profile
Name
Clearside Biomedical Inc
Sector
Industry
Phone
678-270-3631
Address
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Compare CLSD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
0.3841 | 32.37M | 8.23M | -32.49M | -19.91M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-18-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-18-25 | Downgrade | Stifel | Buy → Hold |
| Aug-21-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-25-24 | Initiated | Oppenheimer | Outperform |
| Dec-15-21 | Resumed | Wedbush | Outperform |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| May-13-20 | Initiated | ROTH Capital | Buy |
| Aug-09-19 | Downgrade | Needham | Buy → Hold |
| Nov-05-18 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-05-18 | Downgrade | JP Morgan | Overweight → Underweight |
| Nov-05-18 | Downgrade | Stifel | Buy → Hold |
| Mar-06-18 | Reiterated | Needham | Buy |
| May-25-17 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-17 | Initiated | JP Morgan | Overweight |
| Nov-10-16 | Reiterated | Needham | Buy |
| Oct-24-16 | Reiterated | Stifel | Buy |
View All
Clearside Biomedical Inc Stock (CLSD) Latest News
How Resilient Is Clearside Biomedical Inc. Stock During Economic DownturnsStock Entry Point Planner with Volume Spike - Newser
Strategies to average down on Clearside Biomedical Inc.Market Stability and Long-Term Growth Outlook - Newser
Chart based exit strategy for Clearside Biomedical Inc.Free Alpha Driven Watchlist With Alerts - Newser
Competitive Positioning of Clearside Biomedical Inc.: Is It Leading or LaggingPortfolio Booster Strategy with Trend Confidence - Newser
How does Clearside Biomedical Inc. compare to its industry peersSwing Trade Outlook For Every Investor - jammulinksnews.com
Is Clearside Biomedical Inc. a growth stock or a value stockFinancial News Outlook For 2025 - jammulinksnews.com
Chart overlay techniques for tracking Clearside Biomedical Inc.Sector-Wise Equity Performance Trend Forecast - Newser
Advanced analytics toolkit walkthrough for Clearside Biomedical Inc.Triple Digit Gain Opportunity Watchlist - Newser
Automated trading signals detected on Clearside Biomedical Inc.Free Smart Allocation Stock Pick Insights - Newser
Using data tools to time your Clearside Biomedical Inc. exitExpert-Backed High Yield Stock Watchlist - Newser
Clearside Biomedical Inc. stock outlook for YEARSwing Entry Risk Mitigation with Chart Analysis - Newser
Is Clearside Biomedical Inc. stock overvalued or undervaluedPost Market Picks With Low Risk - jammulinksnews.com
What makes Clearside Biomedical Inc. stock price move sharplyFree Community Verified Stock Suggestions - Newser
Why is Clearside Biomedical Inc. stock attracting strong analyst attentionBest Dividend Insights For Consistent Profits - jammulinksnews.com
What is Clearside Biomedical Inc. company’s growth strategyMarket Forecast Tracker For Smart Trading - jammulinksnews.com
Why Clearside Biomedical Inc. stock is on top investor watchlistsLong-Term Allocation Strategy Summary Breakdown - Newser
What institutions are buying Clearside Biomedical Inc. stock nowRisk Shielded Trade Watch with Analysis - Newser
Clearside Biomedical Inc. stock prediction for this weekFree Oversold Recovery Opportunity Stocks - Newser
Using portfolio simulators with Clearside Biomedical Inc. includedLong-Term Signal Tracking and Profit Summary - Newser
Clearside Biomedical Inc. Breakout Confirmed by Volume MetricsAI Based High Gain Watchlist Scanner Shared - metal.it
Published on: 2025-07-30 14:02:11 - metal.it
How Clearside Biomedical Inc. stock performs during market volatilityFree Strong Buy With Technical Confidence - Newser
Published on: 2025-07-30 04:08:22 - metal.it
Clearside Biomedical Skyrocketed 17.9% – What’s Fueling This Volatility? - AInvest
Published on: 2025-07-29 04:01:20 - Newser
Does Clearside Biomedical Inc. stock perform well during market downturnsPre Market Entry Points To Watch Now - jammulinksnews.com
Can Clearside Biomedical Inc. Rally Enough to Break EvenInvestment Plan With Growth Optimization Finalized - metal.it
Is it the right time to buy Clearside Biomedical Inc. stockBuild a diversified portfolio for stability - jammulinksnews.com
What are Clearside Biomedical Inc. company’s key revenue driversUnlock your portfolio’s hidden potential - jammulinksnews.com
When is Clearside Biomedical Inc. stock expected to show significant growthSmart Portfolio Strategy For Beginners - jammulinksnews.com
What is the risk reward ratio of investing in Clearside Biomedical Inc. stockBreakthrough profit margins - jammulinksnews.com
How strong is Clearside Biomedical Inc. company’s balance sheetBuild a strong portfolio for long-term success - jammulinksnews.com
Should I hold or sell Clearside Biomedical Inc. stock in 2025Unlock market-leading stock analysis - jammulinksnews.com
How does Clearside Biomedical Inc. generate profit in a changing economyRapid wealth creation - jammulinksnews.com
Clearside Biomedical Inc Stock (CLSD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):